Cyclospora is a recently described new human pathogenic coccidian causing intermittent diarrhoeal enteritis which may persist for weeks or months in immunocompetent subjects, particularly travellers visiting some tropical areas and countries, such as Nepal, the Caribbean, Peru and Mexico. More rarely this enteric pathogen affects immunocompromised humans, namely HIV-infected people or AIDS patients, with same clinical pictures recognized in normal hosts. We describe the first case of Cyclospora sp. and Cryptosporidium parvum associated diarrhoeal enteritis in an adult AIDS patient.
INTRODUCTION

I
n 1986, Soave et al. reported the presence of coccidian-like bodies in the diarrhoeal stools of four American tourists who had spent some time in Haiti and in Mexico, and suggested that they might be a new enteropathogen. More recently, five AIDS patients and three international travellers with a similar diarrhoeal picture and organism were described (Hart et al., 1990; Long et al, 1990) . Although the authors noted that the organisms resembled oocysts of coccidian protozoa, they concluded that they were photosynthetic, thylalkoid algae-like structures (socalled "blue-green algae" or "cyanobacteria-like bodies"), ultrastructurally related to Chlorella spp.
( Long et al., 1990) . Subsequent epidemiological studies showed that this pathogen is more widespread than previously thought, and it is prevalent in Asia, Latin America, and the Caribbean, particularly in Nepal, Peru and Mexico (Shlim et al, 1991; Hoge et al., 1993; Gascon et al., 1993; Ortega et al., 1993) . Two recent studies (Bendall et al., 1993; Ortega et al., 1993) have provided more evidence that the microorganism is a newly defined coccidian protozoan which had gone unrecognized in the human gut before the report of Soave et al. (1986) , and classified it within the genus Cyclospora.
Most reported cases
have been in immunocompetent hosts, with "travellers diarrhoea" (Shlim et al., 1991; Hoge et al., 1993; Gascon et al, 1993; Ortega et al, 1993) . To date, only few cases have been reported in immunocompromised patients, specifically those with HIV infection (Hart et al, 1990; Long et al, 1990; Bendall et al., 1993; Brandonisio et al., 1993; Wurtz et al, 1993) .
We describe the first case of co-infection with parvum. An intestinal biopsy was not performed.
The patient died suddenly of a cardiac arrest on November 18, 1992. Autopsy was not permitted.
DISCUSSION
C hronic diarrhoea is a common problem in symptomatic HIV-infected subjects (Bartlett et al., 1992) . The spectrum of microorganisms potentially responsible for diarrhoea is widening;
however, particularly in tropical areas, several cases are due to coccidian protozoa such as Cryptosporidium parvum and Isospora belli (Soave and Johnson,1988) .
Recently, in some cases of diarrhoeal enteritis in HIV positive patients (Hart et al., 1990; Long et al., 1990; Bendali et al., 1993 ; Brandonisio et al., 1993 ; Wurtz et al., 1993) , the etiological agent has been identified as a new human coccidian of Cyclospora genus accor ding to Ortega et al. (1993) , and previously named "cyanobacterium-like" or "alga-like" by other authors (Long et al.. 1990 and . To our knowledge, this is the first reported case of co-infection with Cyclospora sp. and C. parvum in an AIDS patient.
To date, the vast majority of human infection due to Cyclospora sp. has been reported in immunocompe tent travellers and in foreigners residing in some tro pical areas such as Asia (Nepal), the Caribbean and Latin America (Peru, Mexico) (Shlim et al., 1991; Hoge et ai, 1993; Gascon et al, 1993; Ortega et al, 1993 ). An autochthonous epidemic outbreak in the USA among the medical and nursing staff working at an hospital of Chicago (WHO, 1991) and other spora dic cases elsewhere were also reported (Bendali et al, 1993 : Brandonisio et al. 1993 .
From the epidemiologic point of view, it is significant that our patient lived in Nepal for about two years. It is likely that the treatment schedule with spiramy cin and co-trimoxazole temporarily improved the diarrhoea due to these coccidia, in relation with the partial efficacy of spiramycin on C. parvum (Georgiev, 1993) and the preliminary data of the effectiveness of co-trimoxazole on Cyclospora both in immunocompetent (Madico et al, 1993) and immu nocompromised patients with AIDS (Wurtz et al, 1993) .
We also believe that the negative stool examination biopsy to confirm a complete parasitológica! cure was not performed.
In conclusion, clinicians and laboratory operators should be alerted that Cyclospora sp. is a new etiolo gical agent of diarrhoeal enteritis both in immuno competent and in immunodeficient humans. As in our patient, the possibility of a mixed infection with other intestinal pathogens, namely C. parvum, should also be considered : in these cases the careful microscopic evaluation of oocyst morphology in fresh and acid fast stained specimens is an useful dia gnostic method for differentiating these coccidia.
